Emtricitabine, rilpivirine, and tenofovir and Verzenio

• Generic Name: emtricitabine / rilpivirine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: Complera, Odefsey

Emtricitabine, rilpivirine, and tenofovir is a combination antiviral medicine that is used to treat human immunodeficiency virus (HIV), the virus that can cause acquired immunodeficiency syndrome (AIDS). emtricitabine, rilpivirine, and tenofovir is not a cure for HIV or AIDS.

Emtricitabine, rilpivirine, and tenofovir is for use in adults and children who are at least 12 years old and who weigh at least 77 pounds (35 kilograms).

Emtricitabine, rilpivirine, and tenofovir may also be used for purposes not listed in this medication guide.

• Generic Name: abemaciclib
• Dosage Forms: tablet
• Other Brand Names: Verzenio

Verzenio (abemaciclib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Verzenio is used to treat advanced hormone-related breast cancer.

Verzenio is used for this condition only if your tumor tests negative for a protein called human epidermal growth factor receptor 2 (HER2). HER2 protein can speed the growth of cancer cells.

Verzenio is used when the cancer has progressed or has spread to other parts of the body after treatment with anti-estrogen medication or other chemotherapy.

When used in women, Verzenio is given with another medicine called fulvestrant.